MeSH term
Count | Antirheumatic Agents/*adverse effects | 11 |
Antirheumatic Agents/adverse effects | 1 |
Antirheumatic Agents/*adverse effects/therapeutic use | 6 |
Antirheumatic Agents, Gold/adverse effects | 1 |
Antirheumatic Agents/adverse effects/*therapeutic use | 11 |
Antirheumatic Agents/adverse effects/therapeutic use | 5 |
Antirheumatic Agents/*adverse effects/pharmacology | 1 |
Antirheumatic Agents/adverse effects/pharmacology/therapeutic use | 1 |
Antirheumatic Agents, Gold/*adverse effects/therapeutic use | 1 |
Antirheumatic Agents/*administration & dosage/adverse effects | 5 |
Antirheumatic Agents/*adverse effects/immunology/metabolism | 1 |
Antirheumatic Agents/adverse effects/pharmacokinetics/*therapeutic use | 1 |
Antirheumatic Agents/administration & dosage/adverse effects | 1 |
Antirheumatic Agents/administration & dosage/*adverse effects | 2 |
Antirheumatic Agents/administration & dosage/*adverse effects/immunology | 1 |
Antirheumatic Agents, Gold/administration & dosage/*adverse effects | 1 |
*Antirheumatic Agents | 1 |
Antirheumatic Agents/*pharmacology | 14 |
Antirheumatic Agents/therapeutic use | 32 |
Antirheumatic Agents/*therapeutic use | 57 |
Antirheumatic Agents/economics | 2 |
Antirheumatic Agents/pharmacology | 4 |
Antirheumatic Agents/*chemistry/pharmacology | 1 |
Antirheumatic Agents/*metabolism/therapeutic use | 1 |
Antirheumatic Agents/pharmacokinetics/*pharmacology | 1 |
Antirheumatic Agents/*blood/therapeutic use | 1 |
Antirheumatic Agents/economics/*therapeutic use | 1 |
Antirheumatic Agents, Gold/*toxicity | 1 |
Antirheumatic Agents/*pharmacology/therapeutic use | 5 |
Antirheumatic Agents/metabolism/*therapeutic use | 1 |
Antirheumatic Agents/*administration & dosage | 6 |
Antirheumatic Agents, Gold/*therapeutic use | 1 |
Antirheumatic Agents/pharmacology/*therapeutic use | 2 |
Antirheumatic Agents/administration & dosage | 5 |
Antirheumatic Agents, Gold/*pharmacology | 3 |
Antirheumatic Agents/immunology/*therapeutic use | 5 |
Antirheumatic Agents, Gold/therapeutic use | 2 |
Antirheumatic Agents, Gold/pharmacology | 1 |
Antirheumatic Agents/pharmacokinetics/pharmacology | 1 |
Antirheumatic Agents/metabolism/*pharmacology | 1 |
Antirheumatic Agents/administration & dosage/*therapeutic use | 5 |
Antirheumatic Agents, Gold/*pharmacology/therapeutic use | 1 |
Antirheumatic Agents/antagonists & inhibitors/*pharmacology | 1 |
Antirheumatic Agents/diagnostic use/metabolism/*therapeutic use | 1 |
Antirheumatic Agents/administration & dosage/therapeutic use | 2 |
Antirheumatic Agents/isolation & purification/*therapeutic use | 1 |
Antirheumatic Agents/administration & dosage/pharmacology | 1 |
Antirheumatic Agents/*chemical synthesis/*pharmacokinetics/pharmacology | 1 |
Antirheumatic Agents/*chemical synthesis/pharmacology/therapeutic use | 1 |
Antiparkinson Agents/adverse effects | 1 |
Hypoglycemic Agents/*adverse effects | 3 |
Antitrichomonal Agents/adverse effects | 1 |
Antidepressive Agents/adverse effects | 1 |
Antisickling Agents/*adverse effects | 2 |
Antiparkinson Agents/*adverse effects | 2 |
Immunosuppressive Agents/*adverse effects | 39 |
Antihypertensive Agents/adverse effects | 4 |
Alkylating Agents/adverse effects | 1 |
Gastrointestinal Agents/adverse effects | 1 |
Cardiovascular Agents/adverse effects | 1 |
Vasodilator Agents/*adverse effects | 1 |
Antifungal Agents/adverse effects | 1 |
Antipsychotic Agents/adverse effects | 12 |
Chelating Agents/*adverse effects | 1 |
Antifungal Agents/*adverse effects | 2 |
Fibrinolytic Agents/*adverse effects | 1 |
Antiviral Agents/*adverse effects | 8 |
Dopamine Agents/*adverse effects | 2 |
Antitubercular Agents/*adverse effects | 4 |
Anti-HIV Agents/*adverse effects | 16 |
*Antitubercular Agents/adverse effects | 1 |
Antihypertensive Agents/*adverse effects | 12 |
Abortifacient Agents/*adverse effects | 2 |
Dermatologic Agents/adverse effects | 1 |
Fibrinolytic Agents/adverse effects | 1 |
Immunosuppressive Agents/adverse effects | 21 |
*Anti-HIV Agents/adverse effects | 1 |
*Abortifacient Agents/adverse effects | 2 |
Dermatologic Agents/*adverse effects | 1 |
Antineoplastic Agents/*adverse effects | 51 |
Sunscreening Agents/adverse effects | 1 |
Antipsychotic Agents/*adverse effects | 19 |
Anti-HIV Agents/adverse effects | 4 |
Antitubercular Agents/adverse effects | 1 |
Antineoplastic Agents/adverse effects | 30 |
Alkylating Agents/*adverse effects | 1 |
Antiviral Agents/adverse effects | 2 |
*Anabolic Agents/adverse effects | 1 |
Cardiovascular Agents/*adverse effects | 1 |
Antidepressive Agents/*adverse effects | 4 |
Gastrointestinal Agents/*adverse effects | 2 |
Contraceptive Agents/adverse effects | 1 |
Antiviral Agents/*adverse effects/toxicity | 1 |
Anti-Bacterial Agents/adverse effects | 9 |
Vasodilator Agents/adverse effects/*therapeutic use | 5 |
Antineoplastic Agents, Hormonal/*adverse effects | 4 |
Anti-Bacterial Agents/*adverse effects | 12 |
Antihypertensive Agents/adverse effects/*pharmacokinetics | 1 |
Anti-HIV Agents/*adverse effects/*therapeutic use | 1 |
Anti-HIV Agents/adverse effects/pharmacology | 1 |
